Do we really listen to the feedback of our Scientific Leaders? How can we get unbiased feedback on our programs?
Scientific Leaders (SLs) have tremendous knowledge that can be valuable to pharmaceuticals. But asking the right questions and getting honest feedback into the system can be tough.
Live medical congresses are happening again. Are they any better than they used to be?
Has anything changed for the better? Did we learn anything from virtual meetings? And what else could change?